Skip to main content
Aclaris Therapeutics, Inc. logo

Aclaris Therapeutics, Inc. — Investor Relations & Filings

Ticker · ACRS ISIN · US00461U1051 LEI · 5493000B2LQ9QTW1DF52 US Manufacturing
Open in API
Filings indexed 844 across all filing types
Latest filing 2024-12-31 Capital/Financing Update
Country US United States of America
Listing US ACRS

About Aclaris Therapeutics, Inc.

https://www.aclaristx.com/

Aclaris Therapeutics, Inc. is a clinical-stage biopharmaceutical company dedicated to developing novel drug candidates for immuno-inflammatory diseases. The company leverages its core expertise in drug discovery, development, and kinase inhibition to create a pipeline of both small and large molecule drugs. Aclaris focuses on translating scientific discovery into innovative therapies to address the needs of patients with underserved conditions.

Recent filings

Filing Released Lang Actions
424B3
Capital/Financing Update Classification · 95% confidence The document is a prospectus filed pursuant to Rule 424(b)(3) related to the resale of shares by selling stockholders following a private placement. It includes detailed information about the offering, use of proceeds, risk factors, and registration rights. The document is a formal disclosure related to capital raising and share registration for resale, typical of a capital or financing update. It is not an annual report, earnings release, or management discussion. It is not a proxy, voting result, or governance document. The presence of terms like 'prospectus', 'registration statement', 'selling stockholders', 'shares of common stock', and 'plan of distribution' clearly indicate this is a Capital/Financing Update filing. The document length is substantial and contains detailed offering information, not just an announcement or a brief notice. Therefore, the correct classification is Capital/Financing Update (CAP).
2024-12-31 English
Capital/Financing Update 2024
Capital/Financing Update Classification · 95% confidence The document is a letter addressed to the SEC requesting acceleration of effectiveness for a Registration Statement on Form S-3, which is related to securities registration and capital raising. It is a formal communication about a filing but does not contain financial statements, management discussion, or detailed financial data. The document length is short (1437 characters) and it is primarily a procedural request rather than a report or detailed announcement. Therefore, it fits best under Capital/Financing Update (CAP) as it pertains to a registration statement for securities offering.
2024-12-27 English
Regulatory Filings 2024
Regulatory Filings
2024-12-26 English
S-3
Regulatory Filings Classification · 95% confidence The document is a Form S-3 Registration Statement filed with the SEC, as indicated by the header and multiple references throughout the text. It is a registration statement under the Securities Act of 1933, used for registering securities for resale by selling stockholders. The document includes a prospectus summary, risk factors, use of proceeds, plan of distribution, and other typical sections of a registration statement. It is not a financial report like an Annual Report (10-K) or Interim Report (IR), nor is it an earnings release or management discussion. It is also not a proxy statement, voting results, or a legal proceeding report. The document is a regulatory filing related to securities registration and resale, which fits the category of Regulatory Filings (RNS). The document length is substantial (15,000 characters), and it contains detailed registration information rather than just an announcement of a report, so it is not a Report Publication Announcement (RPA). Therefore, the best classification is Regulatory Filings (RNS).
2024-12-19 English
Director's Dealing 2024
Director's Dealing
2024-12-12 English
Director's Dealing 2024
Director's Dealing
2024-12-06 English

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.